AI assistant
Sending…
Oncopeptides — Major Shareholding Notification 2024
May 23, 2024
3091_iss_2024-05-23_c78d5d6f-313b-40b8-ad46-16577cb0ad1e.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Issuer Oncopeptides AB
Holder
Nordnet AB (publ)
Instrument
| Instrument | Aktie SE0009414576 |
|---|---|
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 22/05/2024 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 10,821,675 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 10,821,675 |
| Percentage | |
| Directly held shares | 5.02898 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 5.11803 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.11803 % | 10,821,675 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 5.11803 % | 10,821,675 |
| Chain of controlling |
companies | |
| Voting rights % Voting rights Company | ||
| 10,521,957 4.97628 299,718 0.14174 |
Nordnet Pensionsförsäkring AB Nordnet Livsforsikring AS |
|
| Group total holdings |
||
| Voting rights | 10,821,675 | |
| Percentage of voting rights 5.11803 | ||
| Notes (other relevant informations according to law) | ||
Flaggning beräknad på nytt antal utestående aktier (215 186 246) och röster (211 441 841) efter registrerad företrädesemission.
Published
23/05/2024 14:36 Contact Name Amanda Wadenholt Phone 0730451234 Email [email protected]
*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Oncopeptides
Annual Report (ESEF)
2026
Apr 28
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Major Shareholding Notification
2026
Apr 10
Major Shareholding Notification
2026
Apr 2
Major Shareholding Notification
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31